LIUMJEV
"LIUMJEV" is a word mark owned by Eli Lilly and Company, filed at the NIPO on August 12, 2019. It is registered and covers class 5 (Pharmaceuticals).
- Status
- Registered
- Since December 9, 2019
- Filed
- August 12, 2019
- Registered
- December 9, 2019
- Expires
- August 12, 2029
- Application no.
- 201910623
- Registration no.
- 307236
- Office
- NIPO
- Patentstyret (Norwegian Industrial Property Office)
- Mark type
- Word mark
- 1 class
Who owns LIUMJEV
The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.
Owner
Eli Lilly and Company
LLY · Indianapolis, United States
Representative
Bryn Aarflot AS
Bryn Aarflot AS
What the mark covers
The products and services LIUMJEV is filed for, grouped by Nice class.
Farmasøytiske preparater, nemlig farmasøytiske preparater for behandling av alopeci, Alzheimers sykdom, allergisk eksem, autoimmune sykdommer og lidelser, ben- og skjelettsykdommer og -lidelser, kreft, kardio-vaskulære sykdommer, sykdommer og forstyrrelser i sentralnervesystemet, cluster-hodepine, Crohns syksom, demens, dermatologiske sykdommer og forstyrrelser, diabetes, dyslipidemi, endokrine sykdommer og lidelser, gastrointestinale sykdommer og lidelser, hodepiner, hjertelammelse og hjertesvikt, hypoglykemi, betennelser og inflammatoriske sykdommer og lidelser, inflammatorisk tarmsykdom, nyresykdommer og -lidelser, leversykdommer og -lidelser, lupus, psykiske lidelser, metaboliske sykdommer og lidelser, migrene, multippel sklerose, muskelsykdommer og -lidelser, nevrodegenerative sykdommer og lidelser, nevrologiske lidelser, fedme, smerte, Parkinsons sykdom, psoriasis, psoriasis arthropatica, leddgikt, Sjøgrens syndrom, søvnforstyrrelser, spondylartropati, ulcerøs kolitt, diagnostiske midler og stoffer for medisinske formål; radiofarmasøytiske diagnostiske preparater for bruk i diagnostiseringen av nevrodegenerative sykdommer og av onkologi og av smerte.
What has happened so far
Steps recorded by the NIPO, newest first.
- Date of publication of a registered mark
About LIUMJEV
Who owns the trademark "LIUMJEV"?
The NIPO trademark "LIUMJEV" (application 201910623) is owned by Eli Lilly and Company.
What is the status of "LIUMJEV"?
Its status at the NIPO is: registered.
When was "LIUMJEV" registered?
It was registered on December 9, 2019 and is due to expire on August 12, 2029.
Get this data via the API
Everything on this page comes from the Signa API. Pull LIUMJEV and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_019e4bd5-34dd-75fb-8515-bdf53fe9fd1c
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_019e4bd5-34dd-75fb-8515-bdf53fe9fd1c",
"object": "trademark",
"mark_text": "LIUMJEV",
"status": {
"primary": "active",
"stage": "registered"
},
"office_code": "NO",
"application_number": "201910623",
"filing_date": "2019-08-12",
"nice_classes": [
5
],
"owners": [
{
"name": "Eli Lilly and Company",
"entity_id": "ent_019eb749-c2e4-7669-8d85-00996fda299e"
}
]
}